Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study
Mol. Cancer, Dec 09 2023, 22 (1) 200 | https://doi.org/10.1186/s12943-023-01886-9
Global burden of vaccine-associated anaphylaxis and their related vaccines, 1967-2023: A comprehensive analysis of the international pharmacovigilance database
Allergy, Dec 10 2023, | https://doi.org/10.1111/all.15968
Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial
Lancet Haematol., Dec 2023, 10 (12) S2352-3026(23)00315-0 | https://doi.org/10.1016/S2352-3026(23)00315-0